Vaccination Updates for Pharmacists: Herpes Zoster

Thursday, Dec. 9, 2021, 12 p.m. EST

The herpes zoster (shingles) vaccine no longer requires a prescription. This recent change in schedule status helps pave the way for pharmacists to sustainably expand their role as immunizers. Canadians are also becoming more aware of the importance of adult immunizations beyond influenza and COVID-19.

Join pharmacists Pavithra Ravi and Carlene Oleksyn to gain a deeper understanding of why and how pharmacists can play a vital role in shingles vaccination. You will also be better able to:

  • Recognize opportunities in your practice for shingles vaccinations
  • Address workflow and operational considerations for immunization services
  • Understand the key elements for a successful vaccination campaign

There is no cost to participate. This program is an unaccredited learning activity.

Supported by educational funding from GlaxoSmithKline

Click here to register


On demand recordings from live events

The Time is Right: Moving the Needle on Flu Vaccinations

In the coming weeks and months, pharmacists face uncharted territory yet again for influenza vaccinations. After unprecedented upfront demand last year, will Canadians choose COVID-19 vaccinations over flu shots this year? Will they be complacent about flu given the extremely low case count last year—despite the expectation of a resurgence this year due to reduced physical distancing?

This CE webinar will help pharmacists influence patients’ behaviour by reframing the conversation about influenza vaccination. Dr. Zain Chagla, specialist in infection control, will apply learnings and approaches from COVID-19 education and vaccination campaigns to help pharmacists engage more effectively with patients who are historically or newly hesitant about flu vaccination.

Upon participation in this webinar pharmacists will be better able to:

  • Communicate in simple terms the pathophysiology of influenza to patients and caregivers
  • Discuss the rationale for influenza vaccination, with parallels to the COVID-19 pandemic
  • Describe clinical efficacy of influenza vaccines, and therapeutic options
  • Leverage the COVID-19 vaccine campaign to increase uptake of influenza vaccine, especially among high-risk groups

Supported by educational funding from Sanofi Pasteur.

On online version of this webinar, accredited by the Canadian Council on Continuing Education in Pharmacy, will be available soon on our learning site,


Emerging treatment issues in MS: an update for pharmacists

Pharmacists play an important role in helping patients and their caregivers manage treatment around multiple sclerosis. This learning activity provides expertise to help you guide your patients on the latest in MS treatment options, as well as strategies to effectively collaborate with physicians and specialists around MS patient care plans.

Upon participation you will be better able to:

  • Respond to questions and provide education around common queries about drug therapy
  • Identify the treatment options for the treatment of MS
  • Describe how pharmacists can contribute to improving patient adherence to therapy
  • Identify MS patients who require further assessment by the physician
  • Collaborate effectively with physicians to assist patients with their MS treatment care plan

On online version of this webinar, accredited by the Canadian Council on Continuing Education in Pharmacy, is available on our learning site, Click here. Note: You must be logged in to for access.


Influenza in the time of COVID-19

Pharmacists play a pivotal role in delivering Canada’s influenza vaccination campaigns. This year, easing influenza vaccine hesitancy in light of COVID-19 will be more important than ever.

This learning activity discusses guidelines around co-administered vaccines and offer strategies to help improve influenza vaccine coverage. It provides pharmacists with the knowledge needed to guide patients on the use of influenza vaccines in the presence of COVID-19.

Upon participation you will be better able to:

  • Describe methods behind influenza vaccine development.
  • Discuss current vaccine co-administration guidelines including influenza and COVID-19 vaccines.
  • Discuss strategies to overcome influenza vaccine hesitancy.
  • Appreciate best practice recommendations for influenza vaccination implementation in the community pharmacy setting during the COVID-19 pandemic.

Approved for 1.0 CE unit by the Canadian Council on Continuing Education in Pharmacy - CCCEP #1329-2021-3266-L-P

Supported by educational funding from Seqirus, a CSL company

This program is available for credit on our learning site,  Click here.


Protecting Older Adults Against Influenza

Across all jurisdictions, pharmacists have been essential in delivering Canada’s influenza campaigns. Influenza poses an enormous burden on older adults due to their decreased immune status and lower immune response to the standard-dose vaccine.

This learning activity will review the efficacy and safety of available influenza vaccines, which are specially formulated to improve older adults' immunogenicity. It will provide pharmacists with the knowledge needed to discuss these options with their older patients.

This program is accredited by the Canadian Council on Continuing Education in Pharmacy, #1329-2021-3210-L-P. Click here to take the course on eCortex. (Must be logged in to

Supported by educational funding from Seqirus, a CSL company.


Understanding Novel Vaccine Technologies

In addition to existing methods of vaccination, new technologies are being employed to protect people against the viruses causing influenza and COVID-19 infections. To address patients’ concerns and combat vaccine hesitancy, pharmacists must have a good understanding of these novel technologies.

This CE webinar reviews methods of immunization and discuss the differences between egg- and cell-based production of influenza vaccines. Presenter Brett Barrett, who specializes in the management of infection, will provide the knowledge you need to reassure your patients about the safety and efficacy of these interventions.

Supported by educational funding from Seqirus, a CSL company.

NOTE: On on-demand version of this webinar, approved for 1.0 CE unit by the Canadian Council on Continuing Education in Pharmacy, is available on Click here.


Give it a Shot: A New Approach to Vaccine Discussion

Adult immunization has been disrupted by the COVID-19 pandemic. Canada‘s National Advisory Committee on Immunization recommends the continuation of immunization during the pandemic with mitigation of risks of COVID-19 transmission. To improve vaccine uptake during this time, practical strategies that address barriers and challenges to adult immunization are key.

Join pharmacist Ajit Johal and family physician Dr. Christine Palmay in this recorded discussion as they discuss:

  • The factors that challenge immunization, including complacency, confidence and convenience
  • The current guidance available to support immunization and best practices for patient education
  • Counseling strategies to overcome barriers and challenges associated with vaccine uptake, especially in the context of COVID-19

This program is an unaccredited learning activity, supported by GSK.

Click here to view.


RTI during a pandemic: protecting your most vulnerable patients

Influenza and pneumococcal pneumonia are leading causes of hospitalization. As we enter our first full influenza season during the COVID-19 pandemic, the prevention of respiratory tract infections (RTI) in older adults and other high-risk patients is of paramount importance.

In this recorded webinar, held live on Oct. 14, 2020, infectious diseases specialist Dr. Wayne Ghesquiere discusses:

  • Breaking down persistent or lingering barriers due to vaccine hesitancy, given the new reality of COVID-19
  • Recommended influenza and pneumococcal vaccines for older adults and other high-risk patients
  • The risk of co-circulation and co-infection, based on a review of the most current data

This program is brought to you by Pharmacy Practice+Business and the Medical Post. It is an unaccredited learning activity supported by Sanofi Pasteur.

Click here to view.


Influenza and COVID-19: Preparing for the 2020-21 flu season

COVID-19 has forcefully reminded people of their vulnerability to infectious diseases. As influenza season approaches, your patients face a potential double threat to their health. More than ever, vaccination against influenza is an essential preventative measure, particularly for at-risk groups such as adults age 65 and older.

In this recorded webinar, held in August 2020 and attended by more than 1,000 healthcare professionals, Dr. Angel Chu, infectious diseases specialist, Foothills Medical Centre in Calgary, Alberta, and vice-chair of Immunize Canada, will help caregivers better understand the interplay between influenza and COVID-19. She will also:

  • Review the burden of influenza and at-risk groups
  • Discuss how to optimize influenza vaccinations for high-risk populations
  • Share practical tips and tools for maintaining immunizations in light of COVID-19

This program is brought to you by Pharmacy Practice+Business and the Medical Post. It is an unaccredited learning activity supported by Sanofi Pasteur.

Click here to view.


Poop talk to pep talk: Effective probiotics for GI patients

Functional GI disorders create a host of issues, such as bloating, abdominal pain and discomfort, as well as unpredictable issues with bowel movements that can limit a person’s ability to participate in most daily activities. During these stressful pandemic times, your patients are particularly prone to frequent and intense GI symptoms that can impact their health and quality of life. But there are readily available and effective interventions out there. Evidence shows that the right probiotic can make all the difference in improving GI symptoms for your patients.

Dragana Skokovic-Sunjic, a clinical pharmacist and leader in probiotic education in North America, discusses effective probiotics and how you can guide your patients in finding a tailored GI treatment.

After watching this webinar, pharmacists will be able to:

  • Confidently interact with patients suffering from functional gastrointestinal problems
  • Understand the mechanism of action and the role of probiotics in the treatment of common GI conditions
  • Get the knowledge and skills to educate and guide patients in selecting the most appropriate probiotic intervention

This program is an unaccredited learning activity, supported by P&G.

Click here to view.


'Digesting' the human microbiome: its role and enablers in infants and children

Based on decades of scientific research, we have a better understanding of the role of a balanced intestinal microbiota composition in health and disease. In early life especially, the composition of the microbiota profoundly influences the development and maturation of the gastrointestinal tract mucosa.

Dr. Jose Garza, pediatric neurogastroenterologist, and Dragana Skokovic-Sunjic, clinical pharmacist, join for an interactive webinar in which they:

  • Explore the composition and role of the human microbiome, and understand factors that negatively impact its composition
  • Review microbiome enablers and the use of probiotics for the modulation of a healthy microbiota composition
  • Examine real-world evidence involving pediatric patients with functional gastrointestinal disorders, and the outcomes following the use of evidence-based probiotics
  • Learn how to select and integrate probiotics into your practice, and how to counsel parents of children with functional gastrointestinal disorders

Presented by and the Medical Post. This free program is an unaccredited learning activity, supported by Ferring Canada.

Click here to watch now, and order samples of BioGaia pediatric products and patient counselling tools:

Click here to view.


Innovations in Cancer Treatment

CAR-T Therapy for Hematologic Malignancies

Chimeric antigen receptor (CAR)-T cell therapy is a promising new treatment for blood cancers. It is an individualized therapy that harnesses the power of the immune system by genetically modifying cells to enable them to kill cancer. Dr. Mustaqeem Siddiqui, a hematologist oncologist with extensive expertise in CAR-T cell therapy, discusses:

  • how T cells are engineered in a laboratory to make a new protein called a chimeric antigen receptor (CAR), which enables a T cell to recognize a cancer cell that expresses the antigen.
  • the current active clinical trials to examine the use of CAR-T cell therapy earlier in the management of leukemia, lymphoma, and multiple myeloma.
  • the most recent results of FDA-approved uses for CAR-T cell therapy and the optimal time to consider such therapy for patients.

Proton Beam Therapy for Fewer Potential Complications

Radiation oncologist Dr. Anita Mahajan discusses how proton beam therapy helps patients survive their cancers with potentially fewer severe side effects and complications – a benefit that is especially impactful for children with cancer. Gain expertise on how proton beam therapy can be optimized to help your patients battling cancer. Also:

  • Review the latest innovations for treating patients who previously received radiation therapy.
  • Examine how proton beam therapy precisely targets protons to tumours while sparing more healthy tissue and organs.
  • Explore the different types of cancers that benefit most from proton beam treatment.
  • You will be able to submit your own questions during this live session.

Click here to view.


Medical Cannabis: Risks, Myths and Misconceptions

This webinar addresses patients’ and physicians’ most common fears and beliefs about medical cannabis. Dr. Lionel Marks de Chabris, a pain and addiction specialist, has included medical cannabis as a treatment option for patients since 2007. Here he shares his knowledge of this treatment option with respect to many of the common concerns of physicians and patients, with a focus on patient counselling and education.

Topics addressed include:

  • Adverse effects
  • Intoxication and overdose
  • Risk of accidental exposure
  • Psychosis
  • Myocardial infarction
  • Cancer
  • Cannabis use disorder
  • Amotivational syndrome
  • Cannabis hyperemesis syndrome
  • Impaired cognition
  • Withdrawal

Click here to view.


Asthma & COPD: Medical Devices that will Change your Practice

Improving patient outcomes for respiratory patients may be as simple as adding on a medical device to their treatment plan. Healthcare professionals often overlook prescribing and recommending medical devices, which can be an effective way to deliver medication and help drug deposition in the lungs. In this on-demand video, Dr. Alan Kaplan, a family physician with extensive expertise in respiratory care, reviews the latest updates on managing your COPD and asthma patients, examines real-world evidence on patient outcomes with respiratory devices and how they make a difference, offers tips on how to use medical devices in your practice and for talking to patients about device reimbursement.

Click here to view.


Enhancing Flu-ency for Your 65+ Patients

In this webinar, Dr. Brian Aw, pharmacist Umberto Leone and Dr. David Colby explore the overlooked burden of influenza that extends beyond the lung, and why influenza can be considered a cardiorespiratory disease among older adults. They also examine the clinical evidence for immunization against influenza among adults 65 and older, including a review of new recommendations from the updated 2018-19 National Advisory Committee on Immunization; and provide an overview of publicly funded influenza immunization programs for older adults, including updates on the availability of the high-dose influenza vaccine in your province.

Click here to view.